Results of a study on arthritis treatment for lupus nephritis to be presented at medical meeting
The treatment ORENCIA® (abatacept) currently approved for rheumatoid arthritis is being explored as a possible therapy for lupus nephritis (kidney disease). Results will be presented by Richard Furie, MD at the upcoming European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology in Berlin, June 6-9 medical meeting. A member of the S.L.E. Lupus Foundation Medical Advisory Board, Dr. Furie is Director, The Systemic Lupus Erythematosus and Autoimmune Disease Treatment Center and Chief, Division of Rheumatology and Allergy-Clinical Immunology, North Shore-LIJ Health System.